Every encounter between a T cell and a potential target—especially when that target is a developing tumor—begins with a rapid ...

Occult hepatitis B virus (OBI) infection presents a significant global health challenge, notoriously flying under the radar ...

New study uncovers how OBI-associated mutations hijack the LHBs-Akt/mTOR axis to accelerate cell cycle progression and ...

A preclinical study by researchers at The University of Texas MD Anderson Cancer Center, published in Cell, details a connection between the immune system and cuproptosis, a type of copper-induced ...

We are interested in how human cells decide to divide, the signalling regulating mitotic entry and its interplay with DNA-damage checkpoints. Entry into mitosis is regulated by a complex signalling ...

Final Bria-IMT™ Phase 2 data show 55% >1 year and 27% >2-year survival in heavily pre-treated metastatic breast cancer (MBC) patients treated with Bria-IMT regimen selected for Phase 3 TWiST analysis, ...

The artificial intelligence (AI) revolution continues to tout developing drugs faster and at lower cost, but are we there yet? On October 2nd, the FDA cleared an investigational new drug (IND) ...

Measuring COVID-19's impact on diagnosis of cervical cancer by race/ethnicity, age, and region of the United States. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...

Chromosomes are susceptible to damage during their duplication and segregation or when exposed to genotoxic stresses. Left uncorrected, these lesions can result in genomic instability, leading to ...

First-line chemotherapy for advanced esophageal squamous-cell carcinoma results in poor outcomes. The monoclonal antibody nivolumab has shown an overall survival benefit over chemotherapy in ...